Medtronic Reports Strong Q1 Earnings with Broad-Based Growth and Raised Guidance
Medtronic (MDT) reported strong first-quarter results for fiscal year 2027, driven by broad-based revenue growth across its four primary portfolios. Revenue reached $9.8 billion, reflecting a robust 13.7% organic increase fueled by high demand and solid execution in all segments. Adjusted diluted earnings per share (EPS) came in at $1.45, surpassing internal expectations due to strong sales performance and disciplined cost management. The company raised its full-year guidance for both revenue and adjusted EPS based on the first-quarter results. Medtronic also highlighted significant growth across several key areas: cardiac ablation solutions surged 88% globally following the Sphere-9 launch, diabetes revenue rose by nearly 15%, and surgical technologies grew at a double-digit pace in advanced energy products like LigaSure vessel sealing.
Tickers: $MDT